China has become the #2 pharmaceutical market years ahead of projections and continues to be the fastest growing market in the world. China is $50 billion dollars a year into life science and healthcare development through over 160 government funding programs. VC investment, M&A transactions and cross-border partnering deals in China were all up significantly in 2012. ChinaBio® Today focuses exclusively on the rapidly evolving life science industry in China, including biotech, pharma, medical device, diagnostics, services and tools. From our offices in Shanghai and San Diego, our industry analysts provide daily news, commentary and analysis on public and private China life science companies, as well as events and global issues affecting the China market. Visit: ChinaBio Today (http://www.chinabiotoday.com) ChinaBio LLC (http://www.chinabiollc.com)
NMY Investment has an opportunistic value-driven investing strategy. We focus primarily on Asian markets, particularly in Greater China and selectively in Southeast Asia. We emphasize on "margin of safety" in our investments, investing in businesses that are valued at below their intrinsic value. We measure intrinsic value from a company's ability to generate consistent cash flows through business cycles, which is, in turn, impacted by the company's economic moat. We look for catalysts that will enable these shares to realize their fair value in a reasonable period of time, and typically hold our investments for 6-24 months.
I am retired apart from managing family investments - mostly equities. I live near Zürich, Switzerland. I keep physically fit by walking and mentally fit by writing mostly on philosophy, economics and politics. My writing is sometimes published internationally. My hobby is drawing with pencil and the face here is a diversification from female backs that I mostly do. I often work from photos. Anyone interested in my art/ in having a drawing done by me should email me at email@example.com
Mr. Christenson serves as Chief Financial Officer of a Minnesota based health care organization. His previous vocational experience includes 3 years commercial banking experience, 3 years serving as Director of Finance at a medical device manufacturing company and 23 years as President and Chief Financial of a machine vision products manufacturing company. Mr. Christenson holds a B.A. in Economics from St. Olaf College and an M.B.A. in Finance from the University of Michigan.
Un asunto que tiñe la aceptación de Bitcoin es la practicidad, sobre todo a nivel tiempo. ¿Cuánto hay que esperar hasta que el bloque específico que contiene una transacción sea incorporado a la cadena? Para montos pequeños, la transacción se toma cómo válida apenas es notificada a la red. Para montos mayores, se recomienda esperar a que se sumen seis confirmaciones, o sea, una hora. En definitiva, cada comerciante podría establecer el umbral con el que se encuentre cómodo y, desde ya, se estudian maneras de acelerar el proceso sin crear vulnerabilidades ante potenciales atacantes
I am a Master of the arts but am involved in many types of investing and trading. My areas of research are primarily biotechnology and disruptive technology. I am interested in turnaround, contrarian, trend following, and (deep) value situations.
I am developing proprietary, quantitative investment strategies; and I operate a website for investors and others.